ECI TECH (08013.HK): Lau Chi Yuen Resigns as Company Secretary, Chan Suet Ngan Appointed as Successor
NewTimeSpace News: On 9 September 2026, ECI Technology Holdings Limited (stock code: 08013) announced that Mr. Lau Chi Yuen had resigned as the company secretary of the company with effect from 9 September 2026 to focus on other business arrangements. Mr. Lau confirmed that there is no disagreement with the board and no matter relating to his resignation that needs to be brought to the attention of the company's shareholders.
According to the announcement, Ms. Chan Suet Ngan was appointed as the company secretary with effect from 9 September 2026. Ms. Chan holds a Bachelor of Commerce degree from the University of Auckland and has over 23 years of experience in accounting, finance and company secretarial matters. She is a member of CPA Australia and the Hong Kong Institute of Certified Public Accountants. The board expressed its gratitude to Mr. Lau for his contributions during his tenure and welcomed Ms. Chan to the company.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- MICOT PHARMA-B (02335.HK): H shares included in eligible list under Stock Connect
- MICOT PHARMA-B (02335.HK): To Be Included as Hang Seng Composite Index Constituent with Effect from 7 September
- MICOT PHARMA-B (02335.HK): Three XTL6001 Studies Accepted for Presentation at EASD 2026 and ASN Kidney Week 2026, Triple-Agonist Mechanism Gains International Recognition
- MICOT PHARMA-B (02335.HK): Preclinical and Phase I data of neuroprotective candidate MT200605 accepted for oral presentation at 2026 World Stroke Congress; Phase II meets primary endpoint
- MICOT PHARMA-B(02335.HK) closed 102.75% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends